Concepedia

Author

Elizabeth M. Jaffee

Johns Hopkins UniversityORCID

Also Known As

E Jaffee, E M Jaffee, E. Jaffee, E. M. Jaffee, E.M Jaffee, E.M. Jaffee, ELIZABETH M. JAFFEE, EM Jaffee, Elizabeth Jaffee, Elizabeth M Jaffee

1.4K

Publications

55.5K

Citations

110

H-Index

196

Concepts

All Affiliations

Johns Hopkins UniversitySidney Kimmel Comprehensive Cancer CenterJohns Hopkins MedicineBloomberg (United States)Sidney Kimmel Cancer Center
EM

About

Elizabeth M. Jaffee is an author at Johns Hopkins University specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

59

136

21.8K

2

Health Sciences

11

11

769

3

Engineering

7

7

5K

4

Natural Sciences

3

3

325

5

Education

1

1

13

Elizabeth M. Jaffee

×

250

Publications

37.3K

Citations

90

H-Index

YearCitations

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Siân Jones, D. Williams Parsons, Jimmy Lin,

Science

2008

4K

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Glen Dranoff, Elizabeth M. Jaffee, A Lazenby,

Proceedings of the National Academy of Sciences

1993

2.8K

Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts

Ela Elyada, Mohan Bolisetty, Pasquale Laise,

Cancer Discovery

2019

2K

Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens

Alex Y. Huang, Paul T. Golumbek, Mojgan Ahmadzadeh,

Science

1994

1.2K

Exomic Sequencing Identifies <i>PALB2</i> as a Pancreatic Cancer Susceptibility Gene

Siân Jones, Ralph H. Hruban, Mihoko Kamiyama,

Science

2009

808

Novel Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Tumor Vaccine for Pancreatic Cancer: A Phase I Trial of Safety and Immune Activation

Elizabeth M. Jaffee, Ralph H. Hruban, Barbara Biedrzycki,

Journal of Clinical Oncology

2001

592

Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi,

Journal of Clinical Oncology

2015

588

Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis

Takahiro Tsujikawa, Sushil Kumar, Rohan N. Borkar,

Cell Reports

2017

585

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Pedram Argani, Christine A. Iacobuzio–Donahue, Byungwoo Ryu,

PubMed

2001

578

Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

Dung T. Le, Eric R. Lutz, Jennifer N. Uram,

Journal of Immunotherapy

2013

547

Page 1